Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04913103
Title Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL (CLSGMCLPOLA)
Acronym CLSGMCLPOLA
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Czech Lymphoma Study Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries CZE


No variant requirements are available.